CAR-T Therapy (BK2113) Stock Forum and Discussion

Investment ThemesDetailed Quotes

CAR-T Therapy Watchlist

1097.871
+0.044+0.00%

Trading Mar 26 15:27 ET

1103.603High1091.696Low

Constituent Stocks: 10Top Rising: GILD+1.84%

MonkeyGee

1 hour ago

Look at all these Fake News media pumping FUD.

I guess whoever is behind this didn't get the results they wanted. PFE only drops by about 29 cents.
Shorting over 100M, you better have something more than this. You are going to get the mother of all squeeze (MOAS)!
$Pfizer (PFE.US)$ $SPDR S&P 500 ETF (SPY.US)$

US Prosecutors Investigate Tip on Pfizer Vaccine, Wall Street Journal Reports

Deep Sea

2 hours ago

$Pfizer (PFE.US)$
Added some shares at 25.39 to DCA.

Teddy123

2 hours ago

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) outperforms osimertinib with a significant and unprecedented overall survival benefit in patients with EGFR-mutated non-small cell lung canc

$Johnson & Johnson (JNJ.US)$
Game-Changing Clinical Data: New Cancer Drug Combo Extends Survival by 12+ Months

Deep Sea

4 hours ago

$Pfizer (PFE.US)$
Pharma businesses are resilient to economic recession.

Demon Town

4 hours ago

Oh boy… there’s some money behind this… but usually, big money avoids dividend stocks. This isn’t normal…

Teddy123

7 hours ago

New nipocalimab data and real-world research at AAN 2025 highlight positive Phase 3 results and commitment to people living with generalized myasthenia gravis (gMG)

$Johnson & Johnson (JNJ.US)$
Breakthrough Phase 3 Results: New Drug Shows Promise for Myasthenia Gravis, Including Pregnant Patients

Teddy123

14 hours ago

Blujepa (gepotidacin) Approved by US FDA for Treatment of Uncomplicated Urinary Tract Infections (uUTIs) in Female Adults and Pediatric Patients 12 Years of Age and Older

$GlaxoSmithKline (GSK.US)$
Breakthrough: New UTI Antibiotic Blujepa Shows Superior Results in Clinical Trials

ひな☆彡 SOXL ♡

22 hours ago

J&J Update

$Johnson & Johnson (JNJ.US)$
with yesterday’s breakout, it tocuhed the day bolinger. I expect more drop. hopefully in next several trading days.

RIPPER: ABOUT TIME……We have a breakout from neckline. Plenty of time to still enter this one. First target is 159, second target is 152.

105684946

23 hours ago

lousy Pharma stock all time

$Pfizer (PFE.US)$ big time manipulated by insiders i supposed. other big giant pharma company holding at more than a hundred a share and yet this so called giant pharma is almost at all time low. what a joke. Really regret buying this.

72358569

23 hours ago

$Pfizer (PFE.US)$ dead money

No comment yet